A Study of Eloralintide (LY3841136) in Chinese Participants With Obesity or Overweight
- Status
- COMPLETED
- Phase
- PHASE1
Clinical Trials Related to Eli Lilly and Company
Related studies linked through entity extraction aliases.
A Study of Lepodisiran (LY3819469) in Participants With Normal, Mild, Moderate, or Severe Liver Function
- Status
- RECRUITING
- Phase
- PHASE1
A Study of Eloralintide (LY3841136) and Eloralintide With Tirzepatide in Participants With Overweight or Obesity
- Status
- COMPLETED
- Phase
- PHASE1
A Study of Tirzepatide (LY3298176) Compared With Placebo in Adults With Type 1 Diabetes and Obesity or Overweight
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE3
Amyloid Lowering for Alzheimer's in Down's With Donanemab Investigation
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE4
A Study to Investigate Safety, Tolerability and Pharmacokinetics of LAE102 in Postmenopausal Women
- Status
- COMPLETED
- Phase
- PHASE1
Implementation pRogram to Improve Screening and Management for CKD in Diabetes (IRIS-CKD) (Program 2)
- Status
- RECRUITING
- Phase
- NA
Implementation pRogram to Improve Screening and Management for CKD in Diabetes (Program 1) (IRIS-CKD)
- Status
- RECRUITING
- Phase
- NA
The Effect of Galcanezumab-gnlm on Post-Traumatic, Migrainous Headaches
- Status
- COMPLETED
- Phase
- PHASE4
A Study of Bimagrumab (LY3985863) and Tirzepatide (LY3298176), Alone or in Combination, in Participants With Obesity or Overweight With Type 2 Diabetes
- Status
- WITHDRAWN
- Phase
- PHASE2
A Study of LY3457263 Compared With Placebo in Participants With Type 2 Diabetes on a Stable Dose of Semaglutide or Tirzepatide
- Status
- RECRUITING
- Phase
- PHASE2
PROGRESS: Precision Oncology Using Genomic Reflexive Evaluations for Study Selection and Survival
- Status
- RECRUITING
- Phase
- NA
A Study of Bimagrumab Alone (LY3985863) and Bimagrumab With Tirzepatide (LY900042) in Healthy Participants
- Status
- COMPLETED
- Phase
- PHASE1
Study of Olomorasib (LY3537982) in Combination With Standard of Care in Participants With Resected or Unresectable KRAS G12C-mutant Non-Small Cell Lung Cancer
- Status
- RECRUITING
- Phase
- PHASE3
A Study of (LY3527727) Pirtobrutinib in Participants With Previously Treated Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma or Non-Hodgkin Lymphoma
- Status
- RECRUITING
- Phase
- PHASE4
A Master Protocol to Evaluate the Long-Term Safety of (LY3527727) Pirtobrutinib
- Status
- RECRUITING
- Phase
- PHASE4
A Study of LY3549492 in Japanese Participants With Type 2 Diabetes Mellitus (T2D) and Healthy Japanese Participants
- Status
- COMPLETED
- Phase
- PHASE1
A Trial of Baricitinib in Patients With Cardiac Sarcoidosis
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE2
Mirikizumab in the Treatment of Chronic Inflammatory Conditions of the Pouch
- Status
- RECRUITING
- Phase
- PHASE4
A Study to Investigate Effectiveness of Tirzepatide Following Initiation of Ixekizumab in Participants With Active Psoriatic Arthritis and Overweight or Obesity in Clinical Practice (TOGETHER AMPLIFY-PsA)
- Status
- RECRUITING
- Phase
- PHASE4